Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Current Pharmaceutical Design (2018) This comparative study examines BPC-157's angiogenic properties alongside standard growth factors including VEGF (Vascular Endothelial Growth Factor) and bFGF (basic Fibroblast Growth Factor) in established wound healing models
Notably, the Short Health Scale and the EuroQol 5-Dimensions have shown these enhanced scores
Muscle preservation Some formulations include glycine along with b12, claiming this combination preserves muscle mass during weight loss
BPC-157 has been shown to be effective in treating various medical conditions, such as inflammatory bowel disease (IBD), muscle damage, ulcerative colitis, gastric ulcers, and tendonitis
The shelf life of the original lyophilised powder is similarly defined by the manufacturer's data and SmPC
&srotate=0)
US$ 21.41
US$ 28.36
US$ 23.68
US$ 21.26
US$ 25.85
US$ 21.90
US$ 21.37
US$ 19.99
